Akso Health director Stephen Brown files Form 3

Akso Health Group director Stephen P. Brown has filed an initial Form 3, formally disclosing his status as a director of the company.

Accepted by SEC EDGAR 03/18/2026 - 05:27 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Akso Health Group director Stephen P. Brown has filed an initial Form 3, formally disclosing his status as a director of the company. The excerpt shows no reported share transactions or derivative positions, indicating this filing is primarily administrative and focused on establishing insider reporting status.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Stephen P. Brown’s Form 3 filing for AHG indicate?

The Form 3 filing indicates that Stephen P. Brown is a director of Akso Health Group. It serves as his initial statement as an insider, establishing his reporting status under SEC rules, without showing any share purchases, sales, or derivative positions in this excerpt.

Does the AHG Form 3 for Stephen P. Brown show any stock transactions?

No, the AHG Form 3 excerpt for Stephen P. Brown shows no reported transactions. All buy, sell, acquire, dispose, and exercise counts are zero, meaning this filing functions as an initial ownership and status disclosure rather than a record of trading activity.

What role does Stephen P. Brown have at Akso Health Group (AHG)?

Stephen P. Brown is identified as a director of Akso Health Group in the Form 3. The filing confirms his board role and insider status, which subjects him to ongoing SEC reporting requirements for future transactions in the company’s securities.

Are any derivative securities reported in Stephen P. Brown’s AHG Form 3?

No derivative securities are reported for Stephen P. Brown in this AHG Form 3 excerpt. The derivativeSummary section is empty and derivative transaction counts are zero, indicating no options, warrants, or similar instruments are disclosed here.

What is the purpose of this Form 3 related to Akso Health Group (AHG)?

This Form 3 serves as an initial insider ownership filing for director Stephen P. Brown at Akso Health Group. It establishes his obligation to report future trades, but the excerpt does not list any current transactions or derivative positions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Brown Stephen P

(Last) (First) (Middle)

9 BENT OAK

(Street)

COTO DE CAZA CALIFORNIA 92679

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
Akso Health Group [ AHG ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

No securities are beneficially owned.

	/s/ Stephen Brown	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)